Table 1.
Demographic and basic data of resistant asthmatic subjects recruited in the clinical trial comparing itraconazole with prednisolone
| Total | Itraconazole | Prednisolone | |
|---|---|---|---|
| Number | 103 | 51 | 52 |
| Lost during study | 13 (25%) | 14 (28%) | |
| Age (Years) | 52±15 (18-87) | 49±15* | 56±13 |
| Sex (Female/Male) | 76/23 | 39/12 | 39/12 |
| Duration of asthma (Years) | 8.4±7.9 (1-38) | 8.3±7.8 | 8.7±8.1 |
| Residence (Urban/Rural) | 71/30 | 40/10 | 31/20 |
| Normal CT scan | 83% | 80%* | 100% |
| Occupational air pollution | 12 (12%) | 6 (12%) | 6 (12%) |
| Nasal allergy | 56 (56%) | 31 (63%) | 25 (52%) |
| Urticaria | 52 (52%) | 27 (52%) | 25 (52%) |
| Allergic conjunctivitis | 24 (24%) | 13 (25%) | 11 (22%) |
| At least one allergic symptoms | 63 (63%) | 35 (70%) | 28 (54%) |
*= Significant difference between itraconazole and prednisolone groups